Robert Geho

[Medicxi @medicxi]

This pandemic is bigger than any of us. We @medicxi are with you all the way, Moncef.

[Diasome @Diasome]

Join us tomorrow, August 4 from 3:30 - 4 p.m. ET as we present at the inaugural LifeSci Partners Private Company Virtual Summer Symposium. To register and learn more about our novel approach to rethinking #insulin, click here: https://t.co/LUYAeS3CFa

[Diasome @Diasome]

In this @MDMagazine interview w/ @RealPatCampbell, our CMO Dr. Marc Penn discussed Ph. 2b study results presented at the @AmDiabetesAssn’s 80th Scientific Sessions suggesting that HDV targeting enables hypoglycemia prevention from insulin itself in #T1D: https://t.co/k44D538MYS

[Diasome @Diasome]

We are pleased to announce data showing substantial reductions in Level 2 #hypoglycemia events in our OPTI-1 study of HDV technology in #Type1Diabetes, supporting liver-targeted mealtime insulin as a potential way to decrease time in hypoglycemia: https://t.co/LEa2HgqBWK

[Diasome @Diasome]

We will present data at #ADA2020, the @AmDiabetesAssn's 80th annual meeting, from our Phase 2 study evaluating our hepatocyte directed vesicle (HDV) technology as a way to minimize hypoglycemia in #T1D. Learn more: https://t.co/PpHHowuPws

[LifeSci Communications @LifeSciComms]

We are often tasked with helping our #healthcare clients break down complicated science for various audiences. In this #LifeSciCommsCorner #blog post, Amy Jobe, Ph.D., explains the common threads she has seen in effective science communication: https://t.co/NB8f11lnv3 #SciComms

[Diasome @Diasome]

The @AmDiabetesAssn recently answered questions you may have about #diabetes and #COVID19. Visit here for more information: https://t.co/elK965RDNm

[Diasome @Diasome]

Stay up to date when it comes to #COVID19 and diabetes by reading this article by Julia Flaherty at @BeyondType1. As this is a developing situation, the article is updated regularly with disease statistics, tips and additional resources: https://t.co/OhywNn7IyB

[Diasome @Diasome]

If you or a loved one is looking for more information about living with #Type1Diabetes during the #COVID19 pandemic, you can visit the @JDRF website for disease information, recommendations on supplies, state-level emergency orders and more: https://t.co/LTTPlGs9oy

[FGCU Women's Tennis @FGCU_WTEN]

Update from Coach Vernon....we hope everyone is staying safe & healthy! Go Eagles! #WingsUp #Focused 💪

[Diasome @Diasome]

.@HopeWarshaw, Registered Dietitian and Certified Diabetes Educator, discusses managing #diabetes and how the traditional classifications for diabetes are evolving. Check out her latest blog post, titled “Who with Diabetes REALLY Requires Insulin?” here: https://t.co/gy4agNwNiq

[Diasome @Diasome]

In this month’s issue of @PharmaVOICE, Diasome CEO, Robert Geho, comments on the importance of patient involvement in clinical trials, drug discovery and development. Read more about how Diasome is engaging patients to help spread #diabetes awareness: https://t.co/CqERAK8Sp6

[Diasome @Diasome]

Vanessa Wilson is a blogger currently working toward earning her certification as a licensed pharmacy technician. Check out her latest blog that explores how pharmacists can help manage #diabetes: https://t.co/4SJAfQXgvL

[Diasome @Diasome]

What is HDV? A nanoscale, frisbee-shaped carrier that delivers about 100 #insulin molecules per disc to the liver. Click here to learn why directing insulin to the liver is critical and how Diasome aims to improve #DiabetesTreatment: https://t.co/yNthEdWiJK

[Diasome @Diasome]

Currently available #insulins fail to act the way insulin does in people without #diabetes. Learn more here about how Diasome is rethinking insulin to optimize #InsulinTherapy: https://t.co/fvMeqVxngA

[Diasome @Diasome]

#DYK that according to the @CDCgov, there are about 245,000 emergency department visits a year for hypoglycemia, in people with diabetes? Read more here: https://t.co/8xkL8mLHuj

[Diasome @Diasome]

This morning, we announced positive Phase 2 results demonstrating that our HDV tech can reduce the time people with #T1D spend in hypoglycemia, when relative basal & liver targeted mealtime #insulin doses are optimized: https://t.co/brhs4P5nrs #diabetes #WeTellInsulinWhereToGo

[FGCU Women's Tennis @FGCU_WTEN]

The match is tied 2-2.

1⃣ Ornberg (6-4, 2-6, 6-5)
2⃣ Momose (6-4, 7-5)
3⃣ Kelly (2-6, 7-5, 2-2)
4⃣ Perez (6-4, 2-6, 6-5)
5⃣ Retortillo (2-6, 6-4, 6-4)
6⃣ Ferding (6-7, 6-7)

[Diasome @Diasome]

To achieve optimal outcomes in #diabetes, all three key components of #InsulinTherapy need to be addressed: dosage, timing, and location. At Diasome, #WeTellInsulinWhereToGo. Find out why ensuring injected insulin can reach the liver is so important: https://t.co/ZcFTPAIX8L

[Diasome @Diasome]

“Everyone needs insulin in their bodies at all times and people with type 1 diabetes don’t make insulin.” Continue reading a #Type1Diabetes perspective from advocate and spokesperson Peg Abernathy (@DiabetesMedia): https://t.co/nGaVol5Nd2